GE HealthCare Technologies (GEHC) Cash from Investing Activities (2022 - 2026)

GE HealthCare Technologies' Cash from Investing Activities history runs 5 years deep, the most recent figure standing at -$2.5 billion for Q1 2026.

• Quarterly Cash from Investing Activities fell 514.25% year-over-year to -$2.5 billion in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$3.1 billion (down 177.14% YoY) and the FY2025 annual result came in at -$1.0 billion, down 14.55% from the prior year.
• Cash from Investing Activities was -$2.5 billion for Q1 2026 at GE HealthCare Technologies, down from -$269.0 million in the prior quarter.
• Across five years, Cash from Investing Activities topped out at -$84.0 million in Q2 2023 and bottomed at -$2.5 billion in Q1 2026.
• A 5-year average of -$318.6 million and a median of -$148.0 million in 2025 frame the typical range for Cash from Investing Activities.
• Annual changes were most pronounced in 2025 — Cash from Investing Activities soared 36.1% — and 2026, when it sank 514.25%.
• GE HealthCare Technologies' Cash from Investing Activities stood at -$95.0 million in 2022, then rose by 7.37% to -$88.0 million in 2023, then sank by 172.73% to -$240.0 million in 2024, then fell by 12.08% to -$269.0 million in 2025, then tumbled by 829.37% to -$2.5 billion in 2026.
• Business Quant data shows GEHC's Cash from Investing Activities at -$2.5 billion in Q1 2026, -$269.0 million in Q4 2025, and -$148.0 million in Q3 2025.